![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1691674
¼¼°èÀÇ ´Ü¹éÁúüÇÐ ¿¬±¸ Åø ¹× Áø´Ü ½ÃÀå(2024-2030³â)Proteomics Research Tools and Diagnostics Market, Global, 2024-2030 |
´Ü¹éÁúüÇÐ »ê¾÷Àº ´Ü¹éÁúüÇÐ ÇÁ·ÎÆÄÀϸµ°ú ¹ÙÀÌ¿À¸¶Ä¿ Ž»öÀÇ ¹ßÀüÀ¸·Î Çõ½ÅÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.
¼¼°è ´Ü¹éÁúüÇÐ ¿¬±¸ µµ±¸ ¹× Áø´Ü ½ÃÀåÀº ¿¬±¸ ¹× Á¦¾à ºÎ¹®¿¡ ÈûÀÔ¾î 2024-2030³â°£ ³ôÀº ¼ºÀå·üÀ» ±â·ÏÇϸç Å« ¼öÀÍÀ» âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¹ø¿ª ¿¬±¸, ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼, ÀǾàǰ °³¹ß °úÁ¤¿¡¼ ´Ü¹éÁúüÇа¡ Á¦°øÇÏ´Â Å« ÀÌÁ¡ÀÌ ÀÌ·¯ÇÑ °·ÂÇÑ ¼ºÀå¼¼¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ´Ü¹éÁúüÇÐ ¿¬±¸ µµ±¸ ¹× Áø´Ü ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ÀÓ»ó ¹× ¿¬±¸ ȯ°æ¿¡¼ ´Ü¹éÁúüÇÐ ¿¬±¸ µµ±¸ ¹× Áø´ÜÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â ¿äÀΰú ¾ïÁ¦ÇÏ´Â ¿äÀÎÀ» Æò°¡Çß½À´Ï´Ù. ¶ÇÇÑ ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿/¾ÆÇÁ¸®Ä«, ³²¹Ì(MEASA)ÀÇ °¢ Áö¿ª°ú °¢ Áö¿ªÀÇ ÁÖ¿ä ÁøÃâ ±â¾÷µé¿¡ ´ëÇØ¼µµ ºÐ¼®ÇÏ¿´½À´Ï´Ù.
The Proteomics Industry is Experiencing Transformational Growth Due to Advancements in Proteomics Profiling and Biomarker Discovery
In the study, Frost & Sullivan examines the global proteomics research tools and diagnostics market, covering different product types, end users, and technologies. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones, largely driven by the research and pharmaceutical segments. The increasing demand for precision medicine, along with the substantial benefits of proteomics in translational research, biomarker discoveries, and drug development processes, lead to this robust growth.
This analysis assesses the factors driving and restraining the use of proteomics research tools and diagnostics in clinical and research settings. In addition, it offers a regional analysis for North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA); major companies participating in each region are also analyzed. The study also identifies the major growth opportunities by evaluating the industry segments, regulatory environment, and emerging business models, as well as revenues and forecasts.